Bortezomib is a common multiple myeloma therapy that can cause treatment-related peripheral neuropathy, a risk factor for falls. The relationship between bortezomib and falls in older patients with multiple myeloma is unknown. In a recent study published in the Journal of Geriatric Oncology, in older adults with multiple myeloma, bortezomib was associated with an increased risk of having a diagnostic …